Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.

scientific article published on 26 October 2005

Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CARCIN/BGI248
P698PubMed publication ID16251207

P50authorBarbara WappenschmidtQ63444312
Peter BugertQ96691995
Rüdiger KlaesQ117235124
Rita SchmutzlerQ21264574
Barbara BurwinkelQ28484015
Michael UntchQ38292680
Alfons MeindlQ63015490
Kari HemminkiQ63213683
P2093author name stringClaus R Bartram
Bernd Frank
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)606-609
P577publication date2005-10-26
P1433published inCarcinogenesisQ326022
P1476titleAssociation of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
P478volume27

Reverse relations

cites work (P2860)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q80195976A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers
Q43721735An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses
Q44712404Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy
Q28392926Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population
Q34801008Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q36681986CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men.
Q36615641CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population
Q36981342Caspase polymorphisms and genetic susceptibility to multiple myeloma
Q33614960Caspase polymorphisms and prognosis of hepatocellular carcinoma
Q36335177Caspase-8 polymorphisms and risk of oral squamous cell carcinoma
Q37860139Caspases and cancer
Q33289658Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
Q35661406Fine-mapping CASP8 risk variants in breast cancer
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q88963822Genetic Modifiers of the Breast Tumor Microenvironment
Q34118402Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma
Q36331604Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q51050036Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
Q53285164Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Q37096057Population differences in breast cancer severity
Q35877750Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer
Q33636988The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck

Search more.